12:00 AM
 | 
Mar 25, 2013
 |  BC Week In Review  |  Clinical News  |  Regulatory

Illumigene Group A Streptococcus regulatory update

Meridian said FDA granted CLIA moderate complexity test categorization for Meridian's illumigene Group A Streptococcus (GAS) test. The in vitro...

Read the full 76 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >